{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:55:07Z","timestamp":1793656507661,"version":"4.5.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","ajkd.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1053\/j.ajkd.2023.11.006","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T09:04:05Z","timestamp":1708160645000},"page":"648-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sodium\/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review"],"prefix":"10.1053","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4097-4606","authenticated-orcid":false,"given":"Chintan V.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: implications for health and disease","volume":"95","author":"De Baaij","year":"2015","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3945\/an.116.012765","article-title":"Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come","volume":"7","author":"Costello","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1053\/j.ajkd.2023.11.006_bib3","author":"Moshfegh"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjmed.2012.06.037","article-title":"Electrolyte disorders in community subjects: prevalence and risk factors","volume":"126","author":"Liamis","year":"2013","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib5","first-page":"283","article-title":"Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals","volume":"14","author":"Schimatschek","year":"2001","journal-title":"Magnes Res"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2215\/CJN.02960906","article-title":"Hypomagnesemia in patients with type 2 diabetes","volume":"2","author":"Pham","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"233","key":"10.1053\/j.ajkd.2023.11.006_bib7","first-page":"35","article-title":"Prevalence of hypomagnesemia among elderly patients attending a tertiary care center: a descriptive cross-sectional study","volume":"59","author":"Gautam","year":"2021","journal-title":"JNMA J Nepal Med Assoc"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1378\/chest.95.2.391","article-title":"Hypomagnesemia in patients in postoperative intensive care [published correction appears in Chest 1989;95(6):1362]","volume":"95","author":"Chernow","year":"1989","journal-title":"Chest"},{"issue":"7","key":"10.1053\/j.ajkd.2023.11.006_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/0972-5229.160272","article-title":"Does magnesium matter in patients of medical intensive care unit: a study in rural Central India","volume":"19","author":"Kumar","year":"2015","journal-title":"Indian J Crit Care Med"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2013.07.025","article-title":"Treatment of hypomagnesemia","volume":"63","author":"Ayuk","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI115317","article-title":"Intestinal absorption of magnesium from food and supplements","volume":"88","author":"Fine","year":"1991","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1053\/j.ajkd.2023.11.006_bib12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1681\/ASN.V1071616","article-title":"Hypomagnesemia","volume":"10","author":"Agus","year":"1999","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1993.tb04153.x","article-title":"A\u00a0comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects","volume":"35","author":"Murdoch","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1681\/ASN.2014030293","article-title":"Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome","volume":"26","author":"Blanchard","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.532","article-title":"Phlorizin: a review","volume":"21","author":"Ehrenkranz","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib16","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1248\/cpb.44.1174","article-title":"Na+-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4\u2032-dehydroxyphlorizin derivatives based on a new concept","volume":"44","author":"Tsujihara","year":"1996","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib17","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1080\/07853890.2020.1841281","article-title":"The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection","volume":"53","author":"Brown","year":"2021","journal-title":"Ann Med"},{"issue":"12","key":"10.1053\/j.ajkd.2023.11.006_bib18","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1007\/s00125-016-4101-6","article-title":"Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials","volume":"59","author":"Tang","year":"2016","journal-title":"Diabetologia"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib19","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13300-017-0232-0","article-title":"Effects of canagliflozin on serum magnesium in patients with type 2 diabetes mellitus: a post hoc analysis of randomized controlled trials","volume":"8","author":"Gilbert","year":"2017","journal-title":"Diabetes Ther"},{"issue":"10","key":"10.1053\/j.ajkd.2023.11.006_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.06.007","article-title":"Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: a post hoc analysis of 10 randomized, placebo-controlled trials","volume":"33","author":"Toto","year":"2019","journal-title":"J\u00a0Diabetes Complications"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4236\/jdm.2017.74019","article-title":"Mechanism underlying increase of the serum magnesium concentration observed following treatment with sodium-glucose cotransporter 2 inhibitors","volume":"7","author":"Sasaki","year":"2017","journal-title":"J\u00a0Diabetes Mellitus"},{"issue":"23","key":"10.1053\/j.ajkd.2023.11.006_bib22","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1042\/CS20201274","article-title":"SGLT2 inhibition versus sulfonylurea treatment effects on electrolyte and acid-base balance: secondary analysis of a clinical trial reaching glycemic equipoise: tubular effects of SGLT2 inhibition in type 2 diabetes","volume":"134","author":"Van Bommel","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.34067\/KID.0006672021","article-title":"Comparative effects of sodium-glucose cotransporter 2 inhibitors on serum electrolyte levels in patients with type 2 diabetes: a pairwise and network meta-analysis of randomized controlled trials","volume":"3","author":"Zhang","year":"2022","journal-title":"Kidney360"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.185","article-title":"Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidney transplant recipients","volume":"4","author":"Song","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.xkme.2020.01.010","article-title":"SGLT2 inhibitors for treatment of refractory hypomagnesemia: a case report of 3 patients","volume":"2","author":"Ray","year":"2020","journal-title":"Kidney Med"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib26","doi-asserted-by":"crossref","first-page":"luac018","DOI":"10.1210\/jcemcr\/luac018","article-title":"Improvement in serum magnesium levels with sodium-glucose cotransporter 2 inhibitors","volume":"1","author":"Saha","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"10","key":"10.1053\/j.ajkd.2023.11.006_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100533","article-title":"Sodium-glucose cotransporter 2 inhibitors and management of refractory hypomagnesemia without overt urinary magnesium wasting: a report of 2 cases","volume":"4","author":"Shah","year":"2022","journal-title":"Kidney Med"},{"issue":"9","key":"10.1053\/j.ajkd.2023.11.006_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100697","article-title":"SGLT2 inhibitors in management of severe hypomagnesemia in patients without diabetes: a report of 4 cases","volume":"5","author":"Shah","year":"2023","journal-title":"Kidney Med"},{"issue":"11","key":"10.1053\/j.ajkd.2023.11.006_bib29","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3390\/nu13114088","article-title":"Effect of dapagliflozin and magnesium supplementation on renal magnesium handling and magnesium homeostasis in metabolic syndrome","volume":"13","author":"Ng","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00586839","article-title":"Simultaneous Mg, Ca, P, K, Na and Cl analysis in rat tubular fluid. II. During acute Mg plasma loading","volume":"340","author":"Le Grimellec","year":"1973","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00586037","article-title":"Phosphate, calcium and magnesium transfers in proximal tubules and loops of Henle, as measured by single nephron microperfusion experiments in the rat","volume":"333","author":"Murayama","year":"1972","journal-title":"Pflugers Arch"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00579944","article-title":"Micropuncture study along the proximal convoluted tubule: electrolyte reabsorption in first convolutions","volume":"354","author":"Le Grimellec","year":"1975","journal-title":"Pflugers Arch"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib33","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1172\/JCI107308","article-title":"Proximal tubule potential difference: dependence on glucose on glucose, HCO3, and amino acids","volume":"52","author":"Kokko","year":"1973","journal-title":"J\u00a0Clin Invest"},{"issue":"48","key":"10.1053\/j.ajkd.2023.11.006_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111247118","article-title":"Claudin-2 and claudin-12 form independent, complementary pores required to maintain calcium homeostasis","volume":"118","author":"Beggs","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib35","doi-asserted-by":"crossref","first-page":"F227","DOI":"10.1152\/ajprenal.00298.2022","article-title":"Magnesium reabsorption in the kidney","volume":"324","author":"De Baaij","year":"2023","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.11.006_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.amjms.2016.08.015","article-title":"Effect of dapagliflozin treatment on fluid and electrolyte balance in diabetic rats","volume":"352","author":"Chen","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.ajkd.2023.11.006_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fphys.2019.00271","article-title":"Empagliflozin contributes to polyuria via regulation of sodium transporters and water channels in diabetic rat kidneys","volume":"10","author":"Chung","year":"2019","journal-title":"Front Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496617","article-title":"Effect of dapagliflozin treatment on the expression of renal sodium transporters\/channels on high-fat diet diabetic mice","volume":"142","author":"Ma","year":"2019","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng889","article-title":"Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family","volume":"31","author":"Schlingmann","year":"2002","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib40","doi-asserted-by":"crossref","first-page":"F1027","DOI":"10.1152\/ajprenal.00634.2017","article-title":"The rise and fall of novel renal magnesium transporters","volume":"314","author":"Sch\u00e4ffers","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib41","doi-asserted-by":"crossref","first-page":"R2001","DOI":"10.1152\/ajpregu.00153.2007","article-title":"Relationship between low magnesium status and TRPM6 expression in the kidney and large intestine","volume":"294","author":"Rond\u00f3n","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","article-title":"Severe hypomagnesaemia in long-term users of proton-pump inhibitors","volume":"69","author":"Cundy","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.kint.2023.07.007","article-title":"Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes","volume":"104","author":"Sen","year":"2023","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1681\/ASN.2008030327","article-title":"EGF increases TRPM6 activity and surface expression","volume":"20","author":"Thebault","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2023.11.006_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2337\/dbi19-0035","article-title":"A\u00a0variation on the theme: SGLT2 inhibition and glucagon secretion in human islets","volume":"69","author":"Hodson","year":"2020","journal-title":"Diabetes"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/jc.2018-00969","article-title":"Glucagon levels during short-term SGLT2 inhibition are largely regulated by glucose changes in patients with type 2 diabetes","volume":"104","author":"Lundkvist","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib47","first-page":"F328","article-title":"Glucagon and arginine vasopressin stimulate Mg2+ uptake in mouse distal convoluted tubule cells","volume":"274","author":"Dai","year":"1998","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1681\/ASN.2014121228","article-title":"Regulation of Mg2+ reabsorption and transient receptor potential melastatin type 6 activity by cAMP signaling","volume":"27","author":"Blanchard","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2021121544","article-title":"Glucose\/fructose delivery to the distal nephron activates the sodium-chloride cotransporter via the calcium-sensing receptor","volume":"34","author":"Bahena-Lopez","year":"2023","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib50","doi-asserted-by":"crossref","first-page":"F1043","DOI":"10.1152\/ajprenal.00463.2020","article-title":"NaCl cotransporter activity and Mg2+ handling by the distal convoluted tubule","volume":"319","author":"Maeoka","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"issue":"28","key":"10.1053\/j.ajkd.2023.11.006_bib51","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.1073\/pnas.1113811109","article-title":"Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy","volume":"109","author":"Nair","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib52","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jdi.12781","article-title":"Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance","volume":"9","author":"Hattori","year":"2018","journal-title":"J\u00a0Diabetes Investig"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib53","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/jdi.12705","article-title":"Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: a subgroup analysis based on patient characteristics","volume":"9","author":"Osonoi","year":"2018","journal-title":"J\u00a0Diabetes Investig"},{"issue":"2","key":"10.1053\/j.ajkd.2023.11.006_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/jdi.12694","volume":"9","author":"Seino","year":"2018","journal-title":"J\u00a0Diabetes Investig"},{"issue":"48","key":"10.1053\/j.ajkd.2023.11.006_bib55","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1093\/eurheartj\/ehac495","article-title":"Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme","volume":"43","author":"Zannad","year":"2022","journal-title":"Eur Heart J"},{"issue":"42","key":"10.1053\/j.ajkd.2023.11.006_bib56","doi-asserted-by":"crossref","first-page":"16488","DOI":"10.1074\/jbc.RA118.003950","article-title":"Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6)","volume":"293","author":"Nie","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1053\/j.ajkd.2023.11.006_bib57","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors on water and sodium metabolism","volume":"13","author":"Tang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.11.006_bib58","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1096\/fj.201802094R","article-title":"Tubular flow activates magnesium transport in the distal convoluted tubule","volume":"33","author":"Verschuren","year":"2019","journal-title":"FASEB J"},{"issue":"8","key":"10.1053\/j.ajkd.2023.11.006_bib59","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3390\/cells10081893","article-title":"Reactive oxygen species downregulate transient receptor potential melastatin 6 expression mediated by the elevation of miR-24-3p in renal tubular epithelial cells","volume":"10","author":"Hirota","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/biom12010143","article-title":"Antioxidant roles of SGLT2 inhibitors in the kidney","volume":"12","author":"Llorens-Cebri\u00e0","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1053\/j.ajkd.2023.11.006_bib61","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/BF00869264","article-title":"Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man","volume":"29","author":"Paolisso","year":"1986","journal-title":"Diabetologia"},{"issue":"6","key":"10.1053\/j.ajkd.2023.11.006_bib62","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/jdi.13309","article-title":"SGLT2 inhibitors for genetic and acquired insulin resistance: considerations for clinical use","volume":"11","author":"Hosokawa","year":"2020","journal-title":"J\u00a0Diabetes Investig"},{"issue":"5","key":"10.1053\/j.ajkd.2023.11.006_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12948","article-title":"Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus","volume":"71","author":"Budoff","year":"2017","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2023.11.006_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.247","article-title":"Canagliflozin, serum magnesium and cardiovascular outcomes: analysis from the CANVAS Program","volume":"4","author":"Wang","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.11.006_bib65","article-title":"Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis [published correction appears in Open Heart. 2018;5(1):e000668corr1]","volume":"5","author":"DiNicolantonio","year":"2018","journal-title":"Open Heart"},{"key":"10.1053\/j.ajkd.2023.11.006_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/DMSO.S233538","article-title":"Extraglycemic effects of\u00a0SGLT2 inhibitors: a review of the evidence","volume":"13","author":"Bonora","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1053\/j.ajkd.2023.11.006_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J\u00a0Pharm Pharmacol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623010065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623010065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T06:38:56Z","timestamp":1714459136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623010065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0272638623010065"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.11.006","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium\/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}